Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients

• Status: Withdrawn
• Trial end date: 2007-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a Phase IV study evaluating triglyceride levels in peritoneal dialysis patients.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Baxter Healthcare Corporation
• Treatments: Dialysis Solutions; Icodextrin; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• written informed consent

• CAPD/APD on dialysis for at least 3 months

• Elevated fasting triglyceride levels

Exclusion Criteria:

• enrolled in another study requiring IRB approval

• allergy to starch-based polymers

• glycogen storage disease

• maltose or isomaltose intolerance

• active alcohol/substance abuse

• Pregnant or nursing

• received an investigational drug within 30 days of screening